Today

Agents

Chat

Arena

Discover

More

App

CAMP4 Therapeutics gets Raymond James strong buy rating, $10 price target

CAMP•2026-10-23

Raymond James initiated coverage of CAMP4 Therapeutics with a strong buy rating and a $10 price target.

Related News

L

Lockheed Martin: Deutsche Bank raises target price to $616 from $568

LMT•2026-10-23

Embraer Q3 order backlog reaches record $35.7 billion

ERJ•2026-10-23

NAGA Group flags risk of deeper stock correction as AI spending concerns mount

SPY•2026-10-23

American Express raises 2026 profit forecast as affluent customers keep spending

AXP•2026-10-23

Nasdaq, Inc.: Deutsche Bank raises target price to $118 from $116

NDAQ•2026-10-23

CAMP4 Therapeutics gets Raymond James strong buy rating, $10 price target - CAMP News | Rallies